Evidence map›Paper›PMID 34282330›Full record

ArticleNature immunology2021

BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells.

Hyungseok Seo, Edahí González-Avalos, Wade Zhang, Payal Ramchandani, Chao Yang, Chan-Wang J Lio, Anjana Rao, Patrick G Hogan

Open access · bronzeAbstract read
In one paragraph

Article in Nature immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 252 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
252citing papers in PubMed, 2 pooled it
21.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

252 citing papers in PubMed, 2 syntheses or guidelines pooled it, 332 citations in OpenAlex.

  1. Mapping the clinical landscape of multifunctional CAR T cells: Targets, trends, and synergies.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Interferon regulatory factors orchestrate CD8International journal of molecular medicine · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Targeting PKM2 Enhances the Anti-Tumor Function of CD8International journal of molecular sciences · 2026
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. EZH2 and intracellular CaCellular & molecular immunology · 2026
    Article
  20. BATF3 regulates differentiation of CD8Life science alliance · 2026
    Article

192 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hyungseok Seo *Division of Signaling and Gene Expression, La Jolla Institute for Immunology, La Jolla, CA, USA.
Edahí González-Avalos *Division of Signaling and Gene Expression, La Jolla Institute for Immunology, La Jolla, CA, USA.
Wade ZhangDivision of Signaling and Gene Expression, La Jolla Institute for Immunology, La Jolla, CA, USA.
Payal RamchandaniDivision of Signaling and Gene Expression, La Jolla Institute for Immunology, La Jolla, CA, USA.
Chao YangDivision of Signaling and Gene Expression, La Jolla Institute for Immunology, La Jolla, CA, USA.
Chan-Wang J LioDivision of Signaling and Gene Expression, La Jolla Institute for Immunology, La Jolla, CA, USA.ORCID http://orcid.org/0000-0003-3876-6741
Anjana RaoDivision of Signaling and Gene Expression, La Jolla Institute for Immunology, La Jolla, CA, USA. arao@lji.org.ORCID http://orcid.org/0000-0002-1870-1775
Patrick G HoganDivision of Signaling and Gene Expression, La Jolla Institute for Immunology, La Jolla, CA, USA. phogan@lji.org.ORCID http://orcid.org/0000-0001-9869-0684
La Jolla Institute for Immunology · US

Funding

SIGNAL TRANSDUCTION AND GENE INDUCTION IN T LYMPHOCYTESR01AI040127 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI HOGAN, PATRICK, RAO, ANJANA · 1996 to 2025
$13.3M
NFAT, bZIP proteins, and transcriptional programs in lymphocytesR01AI109842 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI Patrick Hogan, Anjana Rao · 2014 to 2026
$8.6M
Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck CancersU01DE028227 · NIDCR · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI GUTKIND, JORGE SILVIO, RAO, ANJANA · 2018 to 2022
$4.6M
CyTOF Mass CytometerS10OD018499 · OD · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROTTY, SHANE P · 2014 to 2014
$802k
FACSAria II Cell SorterS10RR027366 · NCRR · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2011 to 2011
$514k
TET-mediated Epigenetic Regulation in the Development and Immunoevasion of B cell LymphomaK22CA241290 · NCI · OHIO STATE UNIVERSITY · PI LIO, JERRY CHAN-WANG · 2020 to 2022
$485k
NFAT, bZIP proteins, and transcriptional programs in lymphocytesR56AI109842 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI HOGAN, PATRICK, RAO, ANJANA · 2019 to 2019
$414k
NCI NIH HHS K22 CA241290NCRR NIH HHS S10 RR027366NIAID NIH HHS R01 AI040127NIAID NIH HHS R01 AI109842NIAID NIH HHS R56 AI109842NIDCR NIH HHS U01 DE028227NIH HHS S10 OD018499
6 · The paper itself

Abstract

The transcription factors nuclear factor of activated T cells (NFAT) and activator protein 1 (AP-1; Fos-Jun) cooperate to promote the effector functions of T cells, but NFAT in the absence of AP-1 imposes a negative feedback program of T cell hyporesponsiveness (exhaustion). Here, we show that basic leucine zipper ATF-like transcription factor (BATF) and interferon regulatory factor 4 (IRF4) cooperate to counter T cell exhaustion in mouse tumor models. Overexpression of BATF in CD8

Indexed as

AnimalsBasic-Leucine Zipper Transcription FactorsCD8-Positive T-LymphocytesCell Line, TumorDisease Models, AnimalFemaleHumansInterferon Regulatory Factor-4Interferon Regulatory FactorsLymphocytes, Tumor-InfiltratingMaleMelanoma, ExperimentalMiceMice, Inbred C57BLMice, TransgenicNeoplasm Recurrence, LocalBasic-Leucine Zipper Transcription FactorsBatf protein, mouseInterferon Regulatory Factor-4Interferon Regulatory FactorsNFATC Transcription FactorsReceptors, Chimeric AntigenTranscription Factor AP-1

Identifiers

PMID34282330
PMCPMC8319109
OpenAlexW3183788950

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.